Research Article
Exploring the Muscle Metabolomics in the Mouse Model of Sepsis-Induced Acquired Weakness
Table 2
Differential metabolic pathways in the muscle of sepsis-AW mouse.
| <!—Col Count:7 | Total | Hit | Raw | Log () | Impact | Compounds |
| mTOR signaling pathway | 4 | 2 | 0.000469 | 7.6632 | 0.5 | Leu and AMP | Valine, leucine, and isoleucine biosynthesis | 23 | 2 | 0.017804 | 4.0283 | 0.33 | Leu and 2-oxobubanoate | cGMP-PKG signaling pathway | 10 | 2 | 0.003406 | 5.6821 | 0.28571 | AMP and cAMP | Purine metabolism | 95 | 3 | 0.033991 | 2.9381 | 0.23 | AMP, GMP, and adenylosuccinate | PI3K-Akt signaling pathway | 4 | 1 | 0.035727 | 3.3319 | 0.2 | AMP | FoxO signaling pathway | 5 | 1 | 0.044464 | 3.1131 | 0.2 | AMP |
|
|